Literature DB >> 24858256

Group-based QSAR and molecular dynamics mechanistic analysis revealing the mode of action of novel piperidinone derived protein-protein inhibitors of p53-MDM2.

Sukriti Goyal1, Sonam Grover2, Jaspreet Kaur Dhanjal2, Chetna Tyagi2, Manisha Goyal1, Abhinav Grover3.   

Abstract

Tumour suppressor p53 is known to play a central role in prevention of tumour development, DNA repair, senescence and apoptosis which is in normal cells maintained by negative feedback regulator MDM2 (Murine Double Minute 2). In case of dysfunctioning of this regulatory loop, tumour development starts thus resulting in cancerous condition. Inhibition of p53-MDM2 binding would result in activation of the tumour suppressor. In this study, a novel robust fragment-based QSAR model has been developed for piperidinone derived compounds experimentally known to inhibit p53-MDM2 interaction. The QSAR model developed showed satisfactory statistical parameters for the experimentally reported dataset (r(2)=0.9415, q(2)=0.8958, pred_r(2)=0.8894 and F-test=112.7314), thus judging the robustness of the model. Low standard error values (r(2)_se=0.3003, q(2)_se=0.4009 and pred_r(2)_se=0.3315) confirmed the accuracy of the developed model. The regression equation obtained constituted three descriptors (R2-DeltaEpsilonA, R1-RotatableBondCount and R2-SssOCount), two of which had positive contribution while third showed negative correlation. Based on the developed QSAR model, a combinatorial library was generated and activities of the compounds were predicted. These compounds were docked with MDM2 and two top scoring compounds with binding affinities of -10.13 and -9.80kcal/mol were selected. The binding modes of actions of these complexes were analyzed using molecular dynamics simulations. Analysis of the developed fragment-based QSAR model revealed that addition of unsaturated electronegative groups at R2 site and groups with more rotatable bonds at R1 improved the inhibitory activity of these potent lead compounds. The detailed analysis carried out in this study provides a considerable basis for the design and development of novel piperidinone-based lead molecules against cancer and also provides mechanistic insights into their mode of actions.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Library; MDM2; Piperidinone; QSAR; p53

Mesh:

Substances:

Year:  2014        PMID: 24858256     DOI: 10.1016/j.jmgm.2014.04.015

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  4 in total

1.  Structural investigations of T854A mutation in EGFR and identification of novel inhibitors using structure activity relationships.

Authors:  Sukriti Goyal; Salma Jamal; Asheesh Shanker; Abhinav Grover
Journal:  BMC Genomics       Date:  2015-05-26       Impact factor: 3.969

2.  Fragment based group QSAR and molecular dynamics mechanistic studies on arylthioindole derivatives targeting the α-β interfacial site of human tubulin.

Authors:  Chetna Tyagi; Ankita Gupta; Sukriti Goyal; Jaspreet Dhanjal; Abhinav Grover
Journal:  BMC Genomics       Date:  2014-12-08       Impact factor: 3.969

3.  Molecular modeling and lead design of substituted zanamivir derivatives as potent anti-influenza drugs.

Authors:  Dhwani Dholakia; Sukriti Goyal; Salma Jamal; Aditi Singh; Asmita Das; Abhinav Grover
Journal:  BMC Bioinformatics       Date:  2016-12-22       Impact factor: 3.169

4.  Novel group-based QSAR and combinatorial design of CK-1δ inhibitors as neuroprotective agents.

Authors:  Kopal Joshi; Sukriti Goyal; Sonam Grover; Salma Jamal; Aditi Singh; Pawan Dhar; Abhinav Grover
Journal:  BMC Bioinformatics       Date:  2016-12-22       Impact factor: 3.169

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.